Cargando…

The value of Phosphohistone H3 as a cell proliferation marker in oral squamous cell carcinoma. A comparative study with Ki-67 and the mitotic activity index

BACKGROUND: The Phosphohistone H3 (PHH3) antibody is recognized as a biomarker of cell proliferation, specific for cells in mitosis, of prognostic value in different malignant neoplasms, however it has been poorly studied in oral squamous cell carcinoma (OSCC). The main objective of this study was t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tancredi-Cueto, Natalia, Vigil-Bastitta, Gabriela, Bologna-Molina, Ronell, Beovide‑Cortegoso, Verónica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medicina Oral S.L. 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445610/ https://www.ncbi.nlm.nih.gov/pubmed/35975799 http://dx.doi.org/10.4317/medoral.25420

Ejemplares similares

Assessment of tumour proliferation by use of the mitotic activity index, and Ki67 and phosphohistone H3 expression, in early‐stage luminal breast cancer
por: van Steenhoven, Julia E C, et al.
Publicado: (2020)

Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumor
por: Bologna-Molina, Ronell, et al.
Publicado: (2013)

Digital Image Analysis of the Proliferation Markers Ki67 and Phosphohistone H3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Accuracy of Grading Compared With Routine Manual Hot Spot Evaluation of the Ki67 Index
por: Lea, Dordi, et al.
Publicado: (2021)

The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer
por: Klintman, Marie, et al.
Publicado: (2013)

The value of phosphohistone H3 as a proliferation marker for evaluating invasive breast cancers: A comparative study with Ki67
por: Kim, Ji-Ye, et al.
Publicado: (2017)

Immunoexpression of Ki-67, MCM2, and MCM3 in Ameloblastoma and Ameloblastic Carcinoma and Their Correlations with Clinical and Histopathological Patterns
por: Carreón-Burciaga, Ramón Gil, et al.
Publicado: (2015)

Comparison between Manual and Automated Methods for Ki-67 Immunoexpression Quantification in Ameloblastomas
por: González-González, Rogelio, et al.
Publicado: (2016)

Connexin 43, Bcl-2, Bax, Ki67, and E-cadherin patterns in oral squamous cell carcinoma and its relationship with GJA1 rs12197797 C/G
por: Segura, Ignacio González, et al.
Publicado: (2022)

The Utility of Phosphohistone H3 in Inter-Observer Variability of Mitotic Count in Meningioma, is There Any Benefit?
por: Saffar, Hana, et al.
Publicado: (2021)

Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas
por: Duregon, Eleonora, et al.
Publicado: (2016)

Can Histological Grade and Mitotic Index Replace Ki67 to Determine Luminal Breast Cancer Subtypes?
por: Oddó, David, et al.
Publicado: (2018)

Ki-67 labeling index affects tumor infiltration patterns of lung squamous cell carcinoma
por: MASUDA, DAISUKE, et al.
Publicado: (2015)

Ki67 Labelling Index predicts clinical outcome and survival in oral squamous cell carcinoma
por: GADBAIL, Amol Ramchandra, et al.
Publicado: (2021)

Ki-67 acts as a biological surfactant to disperse mitotic chromosomes
por: Cuylen, Sara, et al.
Publicado: (2016)

Mitotic Activity in Gastrointestinal Stromal Tumors: Can we use Phosphohistone H3 Immunohistochemistry Instead of Hematoxylin and Eosin for Mitotic Count?
por: Erhan, Selma Sengiz, et al.
Publicado: (2022)

ki67 nuclei detection and ki67-index estimation: a novel automatic approach based on human vision modeling
por: Barricelli, Barbara Rita, et al.
Publicado: (2019)

A Comparison of Ki67, Syndecan-1 (CD138), and Molecular RANK, RANKL, and OPG Triad Expression in Odontogenic Keratocyts, Unicystic Ameloblastoma, and Dentigerous Cysts
por: Brito-Mendoza, Luisana, et al.
Publicado: (2018)

Cell proliferation markers at the invasive tumor front of oral squamous cell carcinoma: comparative analysis in relation to clinicopathological parameters of patients
por: Veronica, Aurita, et al.
Publicado: (2017)

Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma
por: Rossi, L, et al.
Publicado: (2015)

Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors
por: Manem, Venkata S.K., et al.
Publicado: (2021)

Ki-67 is a PP1-interacting protein that organises the mitotic chromosome periphery
por: Booth, Daniel G, et al.
Publicado: (2014)

Robust linear regression model of Ki-67 for mitotic rate in gastrointestinal stromal tumors
por: KEMMERLING, RALF, et al.
Publicado: (2014)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

What is the Prognostic Significance of Ki-67 Positivity in Oral Squamous Cell Carcinoma?
por: Xie, Shang, et al.
Publicado: (2016)

The Relevance of Assessing the Cell Proliferation Factor Ki-67 in Squamous Cell Carcinoma of the Larynx
por: Vukelic, J., et al.
Publicado: (2019)

Addendum: Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors
por: Manem, Venkata S.K., et al.
Publicado: (2022)

Predictive Ki-67 Proliferation Index of Cervical Squamous Cell Carcinoma Based on IVIM-DWI Combined with Texture Features
por: Li, Cuiping, et al.
Publicado: (2021)

A comparative study of osteopontin expression, Ki67 index and prognosis in squamous cell carcinoma and cysts of the oral cavity
por: Woźniak, Marta, et al.
Publicado: (2020)

Prognostic relevance of the Ki-67 proliferation index in patients with mantle cell lymphoma
por: Jeong, Tae-Dong, et al.
Publicado: (2016)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

The Ki-67 and RepoMan mitotic phosphatases assemble via an identical, yet novel mechanism
por: Kumar, Ganesan Senthil, et al.
Publicado: (2016)

Pulmonary neuroendocrine carcinoid tumors: Is there a predictive role to the Ki 67 index?
por: Patané, Ana Karina, et al.
Publicado: (2021)

Comparison of Ki67 index and P16 expression in different grades of cervical squamous intraepithelial lesions
por: Hosseini, Maryam Sadat, et al.
Publicado: (2023)

Ki-67 is an independent prognostic marker for the recurrence and relapse of oral squamous cell carcinoma
por: Jing, Yue, et al.
Publicado: (2019)

An Immunohistochemical Study on Ki-67 Expression in Squamous Cell Carcinomas of Cervix With Clinicopathological Correlation
por: R, Devaki Priyanka, et al.
Publicado: (2023)

Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer
por: Aziz, Sura, et al.
Publicado: (2016)

Clinical Significance of Ki-67 Labeling Index in Pituitary Macroadenoma
por: Paek, Kyung-Il, et al.
Publicado: (2005)

Degree of Resection and Ki-67 Labeling Index for Recurring Meningiomas
por: Menger, Richard, et al.
Publicado: (2017)

Proliferative Index (Ki67) for Prediction in Breast Duct Carcinomas
por: Ahmed, Shatha Th, et al.
Publicado: (2018)

Decompression induces inflammation but do not modify cell proliferation and apoptosis in odontogenic keratocyst
por: Trujillo-González, Daniela, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qk4a3a8tigvpj7vqsituhrmnkh